Apellis Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Mar 24 | Sell€983,563 | Epidarex Capital | Company | 18,681 | €52.65 | |
18 Mar 24 | Sell€518,813 | Mark Delong | Individual | 9,913 | €52.34 | |
15 Mar 24 | Sell€9,541 | James Chopas | Individual | 184 | €51.85 | |
13 Mar 24 | Sell€590,102 | Nur Nicholson | Individual | 11,220 | €53.12 | |
12 Feb 24 | Sell€37,556 | Mark Delong | Individual | 597 | €62.91 | |
12 Feb 24 | Sell€90,021 | Timothy Sullivan | Individual | 1,431 | €62.91 | |
12 Feb 24 | Sell€72,218 | Adam Townsend | Individual | 1,148 | €62.91 | |
12 Feb 24 | Sell€49,131 | David Watson | Individual | 781 | €62.91 | |
12 Feb 24 | Sell€249,242 | Cedric Francois | Individual | 3,962 | €62.91 | |
12 Feb 24 | Sell€72,218 | Pascal Deschatelets | Individual | 1,148 | €62.91 | |
29 Jan 24 | Sell€21,787 | Mark Delong | Individual | 367 | €59.37 | |
29 Jan 24 | Sell€16,563 | Jeffrey Eisele | Individual | 279 | €59.37 | |
29 Jan 24 | Sell€168,778 | Cedric Francois | Individual | 2,843 | €59.37 | |
29 Jan 24 | Sell€51,886 | Pascal Deschatelets | Individual | 874 | €59.37 | |
29 Jan 24 | Sell€53,786 | Adam Townsend | Individual | 906 | €59.37 | |
29 Jan 24 | Sell€53,786 | David Watson | Individual | 906 | €59.37 | |
29 Jan 24 | Sell€49,571 | Nur Nicholson | Individual | 835 | €59.37 | |
29 Jan 24 | Sell€53,786 | Timothy Sullivan | Individual | 906 | €59.37 | |
29 Jan 24 | Sell€21,787 | Karen Lewis | Individual | 367 | €59.37 | |
22 Jan 24 | Sell€233,551 | Pascal Deschatelets | Individual | 3,913 | €59.69 | |
22 Jan 24 | Sell€203,708 | Adam Townsend | Individual | 3,413 | €59.69 | |
22 Jan 24 | Sell€249,725 | David Watson | Individual | 4,184 | €59.69 | |
22 Jan 24 | Sell€103,734 | Karen Lewis | Individual | 1,738 | €59.69 | |
22 Jan 24 | Sell€154,765 | Nur Nicholson | Individual | 2,593 | €59.69 | |
22 Jan 24 | Sell€211,944 | Timothy Sullivan | Individual | 3,551 | €59.69 | |
22 Jan 24 | Sell€82,605 | Mark Delong | Individual | 1,384 | €59.69 | |
22 Jan 24 | Sell€63,327 | James Chopas | Individual | 1,061 | €59.69 | |
22 Jan 24 | Sell€95,915 | Jeffrey Eisele | Individual | 1,607 | €59.69 | |
22 Jan 24 | Sell€801,640 | Cedric Francois | Individual | 13,431 | €59.69 | |
16 Jan 24 | Sell€481,504 | Cedric Francois | Individual | 7,851 | €61.33 | |
16 Jan 24 | Sell€100,091 | Karen Lewis | Individual | 1,632 | €61.33 | |
16 Jan 24 | Sell€137,073 | Timothy Sullivan | Individual | 2,235 | €61.33 | |
16 Jan 24 | Sell€113,890 | Nur Nicholson | Individual | 1,857 | €61.33 | |
16 Jan 24 | Sell€100,091 | Pascal Deschatelets | Individual | 1,632 | €61.33 | |
16 Jan 24 | Sell€137,073 | Adam Townsend | Individual | 2,235 | €61.33 | |
16 Jan 24 | Sell€260,040 | David Watson | Individual | 4,240 | €61.33 | |
16 Jan 24 | Sell€26,863 | Jeffrey Eisele | Individual | 438 | €61.33 | |
16 Jan 24 | Sell€100,030 | Mark Delong | Individual | 1,631 | €61.33 | |
16 Jan 24 | Sell€52,989 | James Chopas | Individual | 864 | €61.33 | |
04 Jan 24 | Sell€150,751 | Caroline Baumal | Individual | 2,751 | €54.80 | |
26 Dec 23 | Sell€3,566 | Jeffrey Eisele | Individual | 68 | €52.45 | |
01 Dec 23 | Sell€1,350,888 | Epidarex Capital | Company | 24,000 | €56.29 | |
21 Nov 23 | Sell€223,284 | Cedric Francois | Individual | 5,000 | €44.66 | |
17 Nov 23 | Sell€408,428 | A. Dunlop | Individual | 8,894 | €45.92 | |
23 Oct 23 | Sell€5,669 | Mark Delong | Individual | 131 | €43.27 | |
23 Oct 23 | Sell€5,712 | James Chopas | Individual | 132 | €43.27 | |
17 Oct 23 | Sell€1,111,085 | Epidarex Capital | Company | 24,000 | €46.30 | |
18 Sep 23 | Sell€459,289 | Nur Nicholson | Individual | 10,631 | €43.20 | |
06 Sep 23 | Sell€70,480 | Lukas Scheibler | Individual | 1,756 | €40.14 | |
31 Aug 23 | Sell€20,944 | James Chopas | Individual | 551 | €38.01 |
Insider Trading Volume
Insider Buying: 1JK insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 827 | 0.000625% |
State or Government | 45,130 | 0.0341% |
Individual Insiders | 4,344,854 | 3.29% |
VC/PE Firms | 12,806,342 | 9.68% |
Hedge Funds | 22,468,536 | 17% |
Institutions | 92,565,595 | 70% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,058,071 | €598.8m | -8.44% | 0.1% | |||
12,806,342 | €509.2m | 0% | 86.34% | |||
11,357,425 | €451.6m | 1.65% | 14.71% | |||
11,111,111 | €441.8m | 0% | 5.93% | |||
9,505,866 | €378.0m | -0.52% | 0.01% | |||
7,064,967 | €280.9m | -19.4% | 0.03% | |||
5,494,591 | €218.5m | 2.11% | no data | |||
3,240,513 | €128.9m | -1.08% | 0.08% | |||
2,909,528 | €115.7m | -0.2% | no data | |||
2,806,980 | €111.6m | 0% | 17.85% | |||
2,178,673 | €86.6m | 4.12% | 0.01% | |||
2,131,400 | €84.8m | -8.44% | 0.01% | |||
2,023,614 | €80.5m | -5.66% | 0.18% | |||
1,834,224 | €72.9m | -2.11% | no data | |||
1,726,000 | €68.6m | 0% | 3.92% | |||
1,689,890 | €67.2m | 3.63% | 0.01% | |||
1,593,606 | €63.4m | 106% | 0.03% | |||
1,501,990 | €59.7m | -49% | 0.01% | |||
1,315,282 | €52.3m | -7.46% | 1.36% | |||
1,297,800 | €51.6m | 40.7% | 0.79% | |||
1,186,082 | €47.2m | 316% | 0.05% | |||
1,113,897 | €44.3m | 2.48% | no data | |||
1,073,234 | €42.7m | -20.2% | 0.03% | |||
1,054,440 | €41.9m | 0.09% | 0.18% | |||
1,000,000 | €39.8m | 0% | 1.22% |